Clinical trials
Magnetic Resonance clinical trials
Below are recruiting magnetic resonance clinical trials, each written for real people, not researchers. We’re tracking 794 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07004283Enrolling by invitation
Fetal MRI reference ranges for normal brain development
This study uses fetal MRI scans from a large group of healthy pregnancies to create standard growth charts for brain measurements. This helps doctors better understand normal fetal brain development.
Guangzhou, GuangdongAges 18 years+ - NCT07001748RecruitingPhase 2/Phase 3
Testing abdominal chemo plus standard chemo for stomach cancer spread
This trial tests adding the chemotherapy drug paclitaxel directly into the abdomen (intraperitoneal) along with standard IV chemotherapy for people with stomach or gastroesophageal junction cancer that has spread to the lining of the abdomen. The goal is to see if this combination helps control the cancer better than standard treatment alone.
Irvine, CaliforniaAges 18 years+ - NCT06766422Recruiting
AI tool to better detect and predict brain aneurysm risk
This study uses artificial intelligence to help doctors better see and understand brain aneurysms from MRI or CT scans. It aims to improve how accurately aneurysms are found and whether they are stable or at risk of rupturing.
ShanghaiAges 18 years+ - NCT07001917Enrolling by invitation
MRI to check pancreas and kidney transplant health
This study uses MRI scans to see how well your new pancreas and kidney are working after transplant. It may help doctors monitor your transplant without needing risky procedures.
Wuhan, HubeiAges Any age - NCT07000084RecruitingPhase 3
Testing gemcitabine with BCG for returning bladder cancer
This trial tests whether adding a chemotherapy drug called gemcitabine to the usual BCG therapy can help prevent bladder cancer from coming back again. If you have had BCG before and your cancer returned, this study might offer a more effective treatment option.
Birmingham, AlabamaAges 18 years+ - NCT06993454Recruiting
Exercise and blood sugar in type 2 diabetes with fatty liver
This study looks at how a single session of exercise affects the body's natural sugar production in people with type 2 diabetes and fatty liver. It may help us find better ways to control blood sugar and treat fatty liver.
Orlando, FloridaAges 25–55 - NCT06994429Enrolling by invitation
New MRI to check liver function after transplant
This study uses a new MRI technique to check how well your new liver is working after transplant, without any needles or biopsy. If you have had a liver transplant and are scheduled for an MRI, you may be able to join.
Wuhan, HubeiAges 18–80 - NCT06980077RecruitingPhase 2
Ivonescimab for advanced thymic carcinoma
This trial tests a new drug called ivonescimab for thymic carcinoma that has come back or isn't responding to other treatments. It aims to see if this drug can shrink the cancer and help you feel better.
Davis, CaliforniaAges 18 years+ - NCT06277297Recruiting
Heart MRI study for Takotsubo syndrome patients
This study uses MRI to learn more about Takotsubo syndrome (a temporary heart condition often triggered by stress). If you have been diagnosed with Takotsubo and have had certain heart tests, you may be able to join.
Cagliari, ItalyAges 18 years+ - NCT04257747Recruiting
3T MRI study of hand and forearm blood flow
This study uses a powerful MRI scanner (3 Tesla) to measure blood flow in the arteries of the hand and forearm under normal and certain medical conditions. You may qualify if you’re an adult and can safely have an MRI, either as a healthy volunteer or someone needing specific hand/arm surgery.
AmiensAges 18 years+ - NCT06964737RecruitingPhase 1
CAR T-cell therapy for recurrent brain tumors
This trial tests a new type of immunotherapy called CAR T-cells that target a protein called GARP on your tumor cells. It is for people whose high-grade glioma (a fast-growing brain tumor) has come back after previous treatment.
Columbus, OhioAges 18 years+ - NCT06965101Recruiting
Single-session MRI-guided radiation for spinal cord compression
This trial tests whether one quick radiotherapy session on a special MRI machine (MRL) is as good as standard treatment for people with spinal cord compression caused by cancer that has spread. It aims to make treatment faster and easier for you.
ManchesterAges 18 years+ - NCT06971575Recruiting
Cervical nerve pain imaging study using MRN
This study tests a new MRI technique (MRN) to better see nerve damage in people with a pinched nerve in the neck causing arm weakness. It may help your doctor understand your condition and guide treatment.
New York, New YorkAges 18–60 - NCT06955208Recruiting
Using MRI to Measure Meningioma Stiffness Before Surgery
This study uses a special MRI technique called 3D MRE (magnetic resonance elastography) to measure how stiff a meningioma tumor is. The goal is to see if the stiffness can help predict the tumor’s type and characteristics before surgery.
Shenyang, LiaoningAges 18–80 - NCT06960343Recruiting
Shoulder repair with fat tissue for better healing
This trial tests whether adding a small amount of your own fat tissue to standard shoulder surgery helps the torn tendons heal better and last longer. It is for people with a full-thickness tear of the supraspinatus and infraspinatus tendons that needs arthroscopic repair.
Milan, ItalyAges 18 years+ - NCT06959641RecruitingPhase 2
XL092 for advanced thyroid cancer that no longer responds to radioactive iodine
This trial is testing a new oral medication, XL092, for people with advanced thyroid cancer that has stopped responding to radioactive iodine therapy. The goal is to see if XL092 can slow or stop the cancer from growing.
Torrance, CaliforniaAges 18 years+ - NCT06958328RecruitingPhase 3
Higher dose radiation for locally advanced pancreatic cancer
This trial tests whether giving a higher dose of radiation to the pancreas is safe and effective for people with locally advanced pancreatic cancer who have already had chemotherapy without progression.
Gilbert, ArizonaAges 18 years+ - NCT06940609RecruitingPhase 2
Brain scan study for Long COVID brain fog
This trial studies if brain scans can help understand 'brain fog' in Long COVID. It also looks at how a gentle magnetic stimulation might affect symptoms. If you have ongoing thinking problems after COVID, this study may help find new ways to help.
Albuquerque, New MexicoAges 18–80 - NCT06931340RecruitingPhase 3
Adding chemo to hormone therapy for advanced prostate cancer
This trial is for men with metastatic prostate cancer that has already spread beyond the pelvis. It tests whether adding a chemotherapy drug (docetaxel) to the usual hormone therapy plus apalutamide can help control the cancer better than hormone therapy alone.
Tucson, ArizonaAges 18 years+ - NCT06918132RecruitingPhase 2
Cemiplimab and Fianlimab before lung cancer surgery
This trial tests whether two immunotherapy drugs (cemiplimab and fianlimab) given before surgery can help treat stage IB to IIIB non-small cell lung cancer. You must have a PD-L1 level of at least 1% and your surgeon must think the tumor can be fully removed.
Rochester, MinnesotaAges 18 years+ - NCT06914479RecruitingPhase 1
Gene therapy and valacyclovir for recurrent brain tumors in young people
This trial tests a new gene therapy that uses two special viruses and an oral antiviral drug (valacyclovir) to treat brain tumors that have come back in children and young adults. The therapy is given right after surgery to remove the tumor, with the goal of helping your immune system fight the cancer.
Ann Arbor, MichiganAges 3–39 - NCT06557720Recruiting
Imaging study for hard-to-control epilepsy
This study looks at how different brain scans (like MRI, PET, and EEG) can help find the exact spot where seizures start in people whose epilepsy hasn't been controlled by medicines. It aims to better understand drug-resistant epilepsy so doctors can plan more accurate treatments.
Xi'anAges 18–65 - NCT06906562RecruitingPhase 2
Pemigatinib for advanced pancreatic cancer with FGFR changes
This trial tests a targeted pill, pemigatinib, for people with advanced pancreatic cancer that has a specific FGFR gene change. The study is done entirely through telemedicine, so you can participate from home if eligible.
Birmingham, AlabamaAges 18 years+ - NCT06909201Recruiting
Lung MRI scan to study radiation treatment effects
This study uses a special MRI scan with xenon gas to see how radiation therapy affects your lungs. It may help doctors better understand treatment response and side effects.
Houston, TexasAges 18 years+
Hear when a new Magnetic Resonance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for magnetic resonance?
- Yes. Clin2 currently lists 794 recruiting magnetic resonance studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a magnetic resonance trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a magnetic resonance trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.